An Overview of Genetic Information of Latent Mycobacterium tuberculosis = An Overview of Genetic Information of Latent Mycobacterium tuberculosis

다국어 초록 (Multilingual Abstract)

Mycobacterium tuberculosis has infected more than two billion individuals worldwide, of whom 5%-10% have clinically active disease and 90%-95% remain in the latent stage with a reservoir of viable bacteria in the macrophages for extended periods of time. The tubercle bacilli at this stage are usually called dormant, non-viable, and/or non-culturable microorganisms. The patients with latent bacilli will not have clinical pictures and are not infectious. The infections in about 2%-23% of the patients with latent status become reactivated for various reasons such as cancer, human immunodeficiency virus infection, diabetes, and/or aging. Many studies have examined the mechanisms involved in the latent state of Mycobacterium and showed that latency modified the expression of many genes. Therefore, several mechanisms will change in this bacterium. Hence, this study aimed to briefly examine the genes involved in the latent state as well as the changes that are caused by Mycobacterium tuberculosis . The study also evaluated the relationship between the functions of these genes.

참고문헌 (Reference)

1 PupMed, "pcaA: cyclopropane mycolic acid synthase (Mycobacterium tuberculosis H37Rv)"

2 Hutter B, "Up-regulation of narX, encoding a putative ‘fused nitrate reductase’ in anaerobic dormant Mycobacterium bovis BCG" 178 : 63-69, 1999

3 Berney M, "Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia" 5 : e8614-, 2010

4 Marszalek M, "Two-component systems of Mycobacterium tuberculosis as potential targets for drug development" 71 : 172-178, 2014

5 Heermann R, "Two-component systems in bacteria" Caister Academic Press 181-199, 2012

6 Agarwal R, "Treatment of latent tuberculous infection in India: is it worth the salt?" 22 : 105-106, 2005

7 Beste DJ, "Transcriptomic analysis identifies growth rate modulation as a component of the adaptation of mycobacteria to survival inside the macrophage" 189 : 3969-3976, 2007

8 Caner S, "The structure of the Mycobacterium smegmatis trehalose synthase reveals an unusual active site configuration and acarbose-binding mode" 23 : 1075-1083, 2013

9 Grosset J, "The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy" 53 : 5-12, 1978

10 Sachdeva P, "The sigma factors of Mycobacterium tuberculosis : regulation of the regulators" 277 : 605-626, 2010

11 Rodrigue S, "The sigma factors of Mycobacterium tuberculosis" 30 : 926-941, 2006

12 Lonetto M, "The sigma 70 family : sequence conservation and evolutionary relationships" 174 : 3843-3849, 1992

13 Huaman MA, "The relationship between latent tuberculosis infection and acute myocardial infarction" 66 : 886-892, 2018

14 Daniel TM, "The history of tuberculosis" 100 : 1862-1870, 2006

15 Houben RM, "The global burden of latent tuberculosis infection : a re-estimation using mathematical modelling" 13 : e1002152-, 2016

16 Kendall SL, "The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses" 84 : 247-255, 2004

17 Thanna S, "Targeting the trehalose utilization pathways of Mycobacterium tuberculosis" 7 : 69-85, 2016

18 Banerjee SK, "Targeting multiple response regulators of Mycobacterium tuberculosis augments the host immune response to infection" 6 : 25851-, 2016

19 Welin A, "Survival strategies of Mycobacterium tuberculosis inside the human macrophage" Linköping University 2011

20 Lancaster CR, "Succinate : quinone oxidoreductases : new insights from X-ray crystal structures" 1459 : 422-431, 2000

21 Fang C, "Structures and mechanism of transcription initiation by bacterial ECF factors" 47 : 7094-7104, 2019

22 Li L, "Structural basis for transcription initiation by bacterial ECF sigma factors" 10 : 1153-, 2019

23 Tyagi JS, "Signal transduction systems of mycobacteria with special reference to M. tuberculosis" 86 : 93-102, 2004

24 Park HD, "Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis" 48 : 833-843, 2003

25 Agrawal R, "Rv1027c-Rv1028c encode functional KdpDE two-component system in Mycobacterium tuberculosis" 446 : 1172-1178, 2014

26 Jeong EH, "RshA mimetic peptides inhibiting the transcription driven by a Mycobacterium tuberculosis sigma factor SigH" 339 : 392-398, 2006

27 Sohaskey CD, "Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis" 185 : 7247-7256, 2003

28 Zondervan NA, "Regulation of three virulence strategies of Mycobacterium tuberculosis : a success story" 19 : 347-, 2018

29 Sherman DR, "Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin" 98 : 7534-7539, 2001

30 Sohaskey CD, "Regulation of nitrate reductase activity in Mycobacterium tuberculosis by oxygen and nitric oxide" 151 : 3803-3810, 2005

31 Banaiee N, "Regulation of Mycobacterium tuberculosis whiB3 in the mouse lung and macrophages" 74 : 6449-6457, 2006

32 Kaushal D, "Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH" 99 : 8330-8335, 2002

33 Umesiri FE, "Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis" 30 : 290-326, 2010

34 Nishimoto T, "Purification and properties of a novel enzyme, trehalose synthase, from Pimelobacter sp. R48" 60 : 640-644, 1996

35 Kelkar DS, "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution mass spectrometry" 10 : 2011

36 Hibah NA, "Prevalence of latent tuberculosis infection among multinational healthcare workers in Muhayil Saudi Arabia" 9 : 183-187, 2015

37 Velayati AA, "Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization" 5 : 66-73, 2016

38 Corrales RM, "Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation : consequences for intracellular survival and for phagosome maturation block" 287 : 26187-26199, 2012

39 Gonzalo-Asensio J, "PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence" 3 : e3496-, 2008

40 Kwon KW, "Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K" 7 : 44151-, 2017

41 Beaucher J, "Novel Mycobacterium tuberculosis anti-sigma factor antagonists control sigmaF activity by distinct mechanisms" 45 : 1527-1540, 2002

42 Wayne LG, "Nonreplicating persistence of mycobacterium tuberculosis" 55 : 139-163, 2001

43 Wayne LG, "Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis" 79 : 127-132, 1998

44 Sohaskey CD, "Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration" 190 : 2981-2986, 2008

45 Zhou P, "Mycobacterium tuberculosis two-component systems and implications in novel vaccines and drugs" 22 : 37-52, 2012

46 Zahrt TC, "Mycobacterium tuberculosis signal transduction system required for persistent infections" 98 : 12706-12711, 2001

47 Huang HL, "Mycobacterium tuberculosis malate synthase structures with fragments reveal a portal for substrate/product exchange" 291 : 27421-27432, 2016

48 Kumar R, "Mycobacterium tuberculosis isocitrate lyase(MtbIcl) : role of divalent cations in modulation of functional and structural properties" 72 : 892-900, 2008

49 Voskuil MI, "Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy" 84 : 218-227, 2004

50 Rao V, "Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule" 201 : 535-543, 2005

51 Singh A, "Mycobacterium tuberculosis WhiB3maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response" 5 : e1000545-, 2009

52 Sharma S, "Mycobacterium tuberculosis DevR/DosR dormancy regulator activation mechanism : dispensability of phosphorylation, cooperativity and essentiality of alpha10 helix" 11 : e0160723-, 2016

53 Gengenbacher M, "Mycobacterium tuberculosis : success through dormancy" 36 : 514-532, 2012

54 Honaker RW, "Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy" 76 : 2587-2593, 2008

55 Giffin MM, "Mutational analysis of the respiratory nitrate transporter NarK2of Mycobacterium tuberculosis" 7 : e45459-, 2012

56 Gruber TM, "Multiple sigma subunits and the partitioning of bacterial transcription space" 57 : 441-466, 2003

57 Pang X, "MprAB regulates the espA operon in Mycobacterium tuberculosis and modulates ESX-1 function and host cytokine response" 195 : 66-75, 2013

58 He H, "MprAB is a stressresponsive two-component system that directly regulates expression of sigma factors SigB and SigE in Mycobacterium tuberculosis" 188 : 2134-2143, 2006

59 Bretl DJ, "MprA and DosR coregulate a Mycobacterium tuberculosis virulence operon encoding Rv1813c and Rv1812c" 80 : 3018-3033, 2012

60 Parrish NM, "Mechanisms of latency in Mycobacterium tuberculosis" 6 : 107-112, 1998

61 Pham TV, "Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis" 114 : 7617-7622, 2017

62 Magombedze G, "Latent tuberculosis:models, computational efforts and the pathogen’s regulatory mechanisms during dormancy" 1 : 4-, 2013

63 Velayati AA, "Latent tuberculosis(TB)bacilli : yes or no to preventive chemotherapy" 1 : 1-2, 2012

64 World Health Organization, "Latent TB infection : updated and consolidated guidelines for programmatic management" World Health Organization 2018

65 Bhattacharya M, "Interaction analysis of TcrX/Y two component system from Mycobacterium tuberculosis" 92 : 263-272, 2010

66 Hutter B, "Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis" 167 : 7-11, 1998

67 McDermott W, "Inapparent infection : relation of latent and dormant infections to microbial persistence" 74 : 485-499, 1959

68 Haydel SE, "In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins" 26 : 195-206, 1999

69 Fenhalls G, "In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions" 70 : 6330-6338, 2002

70 Black GF, "Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa" 16 : 1203-1212, 2009

71 Hernandez Pando R, "Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis" 78 : 3168-3176, 2010

72 Graham JE, "Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences(SCOTS)" 96 : 11554-11559, 1999

73 Kalscheuer R, "Handbook of hydrocarbon and lipid microbiology" Springer 527-535, 2010

74 Haydel SE, "Global expression analysis of two-component system regulator genes during Mycobacterium tuberculosis growth in human macrophages" 236 : 341-347, 2004

75 Curcic R, "Gene expression in mycobacteria : transcriptional fusions based on xylE and analysis of the promoter region of the response regulator mtrA from Mycobacterium tuberculosis" 13 : 1057-1064, 1994

76 Haydel SE, "Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator" 184 : 2192-2203, 2002

77 Neidhardt FC, "Escherichia coli and Salmonella:cellular and molecular biology" ASM Press 1227-1231, 1996

78 Wayne LG, "Dormancy of Mycobacterium tuberculosis and latency of disease" 13 : 908-914, 1994

79 O’Neill MB, "Diversity of Mycobacterium tuberculosis across Evolutionary Scales" 11 : e1005257-, 2015

80 Ishikawa E, "Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle" 206 : 2879-2888, 2009

81 Sohaskey CD, "Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2" 290 : 129-134, 2009

82 Adeiza MA, "Diagnosis of latent tuberculosis infection : the tuberculin skin test and interferon gamma release assays" 5 : 35-37, 2011

83 Saini DK, "DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR" 150 : 865-875, 2004

84 Parish T, "Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis" 71 : 1134-1140, 2003

85 Cole ST, "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence" 393 : 537-544, 1998

86 Wisedchaisri G, "Crystal structures of the response regulator DosR from Mycobacterium tuberculosis suggest a helix rearrangement mechanism for phosphorylation activation" 378 : 227-242, 2008

87 Huang CC, "Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis" 277 : 11559-11569, 2002

88 Balkhy HH, "Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia : a population-based study" 11 : 197-201, 2016

89 Kana BD, "Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis" 183 : 7076-7086, 2001

90 Dasgupta N, "Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis" 80 : 141-159, 2000

91 Jordan S, "Cell envelope stress response in Gram-positive bacteria" 32 : 107-146, 2008

92 Smith CV, "Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis" 278 : 1735-1743, 2003

93 Feklistov A, "Bacterial sigma factors: a historical, structural, and genomic perspective" 68 : 357-376, 2014

94 Queiroz A, "Bacterial immunostat : Mycobacterium tuberculosis lipids and their role in the host immune response" 50 : 9-18, 2017

95 Geiman DE, "Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigFdependent genes by microarray analysis" 72 : 1733-1745, 2004

96 Ellenbarger JF, "Anion-pi interactions in computer-aided drug design : modeling the inhibition of malate synthase by phenyl-diketo acids" 58 : 2085-2091, 2018

97 Hutter B, "Analysis of the dormancy-inducible narK2promoter in Mycobacterium bovis BCG" 188 : 141-146, 2000

98 Perez E, "An essential role for phoP in Mycobacterium tuberculosis virulence" 41 : 179-187, 2001

99 Bekierkunst A, "Acute granulomatous response produced in mice by trehalose-6,6-dimycolate" 96 : 958-961, 1968

100 Folkvardsen DB, "A major Mycobacterium tuberculosis outbreak caused by one specific genotype in a low-incidence country : exploring gene profile virulence explanations" 8 : 11869-, 2018